A Follow-up Evaluation Study of PRI-724-1101

6-week Safety and PD Study in Adults With NAFLD

NCT03256526 ·Status: COMPLETED ·Phase: PHASE2

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

NCT02868164 ·Status: WITHDRAWN ·Phase: NA

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

NCT02865369 ·Status: UNKNOWN

An Follow-Up Study of Liver Cirrhosis

NCT03472742 ·Status: COMPLETED

Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects

NCT00244751 ·Status: COMPLETED ·Phase: PHASE2

Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.

NCT02721264 ·Status: UNKNOWN ·Phase: NA

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

A Study of IDN-6556 in Subjects With Liver Cirrhosis

NCT02230670 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C

NCT00119119 ·Status: TERMINATED ·Phase: PHASE3

A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT05692492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Effect of Rifaximin on Portal Vein Thrombosis

NCT03631147 ·Status: UNKNOWN ·Phase: NA

Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)

NCT03248882 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)

NCT06569524 ·Status: RECRUITING ·Phase: PHASE2

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

NCT00492700 ·Status: COMPLETED ·Phase: PHASE2

a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

NCT07128797 ·Status: RECRUITING ·Phase: PHASE1

TAK-242 in Patients With Acute Alcoholic Hepatitis

NCT04620148 ·Status: UNKNOWN ·Phase: PHASE2

A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases

NCT02077374 ·Status: COMPLETED ·Phase: PHASE2

Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis

NCT02400216 ·Status: COMPLETED

Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

NCT06533852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

NCT03439254 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

NCT05297448 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

NCT00295607 ·Status: COMPLETED ·Phase: PHASE2

A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

NCT03420768 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

NCT02855164 ·Status: TERMINATED ·Phase: PHASE2

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

NCT00225901 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2